Hair Silicon as a Long-Term Mineral Exposure Marker in Coronary Artery Disease: A Pilot Study

Ewelina A Dziedzic1, Łukasz Dudek2, Andrzej Osiecki2

  • 1Cardiovascular Clinic, Centre of Postgraduate Medical Education, 01-813 Warsaw, Poland.

Nutrients
|December 31, 2025
PubMed

Insights

Hair silicon levels do not correlate with coronary artery disease (CAD) severity or inflammation. This suggests silicon is not a useful biomarker for advanced cardiovascular disease.

Area of Science:

  • Cardiovascular Research
  • Trace Mineral Metabolism
  • Biomarker Discovery

Background:

  • Coronary artery disease (CAD) is a complex atherosclerotic condition.
  • Silicon (Si) is a trace mineral with potential health benefits, but its role in cardiovascular disease is not well-defined.
  • This study investigated the association between hair silicon concentration and CAD.

Purpose of the Study:

  • To determine if hair silicon levels correlate with the severity of coronary artery disease.
  • To assess the relationship between hair silicon concentration and clinical presentation, risk factors, and systemic inflammation in CAD patients.
  • To evaluate silicon's potential as a diagnostic or prognostic biomarker in CAD.

Main Methods:

  • 130 patients with confirmed CAD were enrolled.
  • Hair silicon concentration was measured using ICP-OES.
  • Associations with CAD severity (CASSS, SYNTAX scores), clinical phenotypes, and biochemical/inflammatory markers were analyzed.

Main Results:

  • No significant association was found between hair silicon levels and CAD severity (CASSS or SYNTAX scores).
  • Hair silicon concentration did not differ between stable angina and acute coronary syndrome patients, or those with/without prior myocardial infarction.
  • Silicon levels were unrelated to age, BMI, cardiovascular risk factors, lipid profiles, or inflammatory markers.

Conclusions:

  • Hair silicon concentration is not associated with CAD severity, clinical phenotype, or systemic inflammation.
  • Long-term silicon exposure appears metabolically neutral in advanced atherosclerosis.
  • Silicon is unlikely to be a diagnostic or prognostic biomarker for CAD, though it may play a role in early vascular remodeling or primary prevention.